← Back to Search

TAU + Written Exposure Therapy (WET) for Substance Use Disorder (WEST Trial)

N/A
Recruiting
Research Sponsored by Potomac Health Foundations
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks, or until the participant discharges from residential treatment (whichever comes first).
Awards & highlights

WEST Trial Summary

This trial aims to assess the effectiveness of a therapy called written exposure therapy (WET) for individuals with posttraumatic stress disorder (PTSD) who are also undergoing residential substance use disorder (S

Who is the study for?
This trial is for individuals with both substance use disorders (SUD) and post-traumatic stress disorder (PTSD), who are currently in a short-term residential treatment program. The study is designed to see if adding written exposure therapy (WET) to their usual care helps reduce PTSD symptoms more than usual care alone.Check my eligibility
What is being tested?
The trial tests the addition of written exposure therapy, a treatment for PTSD, to the standard care given in a residential program for substance abuse. It aims to determine if this combined approach is feasible and effective at reducing PTSD symptoms within the context of severe SUD.See study design
What are the potential side effects?
Since Written Exposure Therapy involves writing about traumatic events, it may cause temporary emotional discomfort or distress. However, it's generally considered low-risk compared to other forms of trauma-focused therapy.

WEST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks, or until the participant discharges from residential treatment (whichever comes first).
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks, or until the participant discharges from residential treatment (whichever comes first). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy of WET
Secondary outcome measures
Acceptability of WET delivered in residential SUD treatment context
Feasibility of WET delivered in residential SUD treatment context

WEST Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TAU + Written Exposure Therapy (WET)Experimental Treatment2 Interventions
Participants in this condition receive everything included in TAU plus 5 individual sessions of WET delivered by a therapist. Sessions average less than 60 minutes and primarily involve writing about the traumatic experience that is guided by the therapist.
Group II: Treatment as Usual (TAU)Active Control1 Intervention
Participants randomized to the TAU condition, which involves the standard clinical services available in a short term residential SUD treatment context. Examples of these services are: Individual counseling/case management; Group psychoeducation; Group counseling; Assessment and addiction related medical treatment from a physician; Pharmacotherapy for substance use disorders; 12-step groups. However, participants in this group do not receive treatment that is targeted at decreasing PTSD symptoms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Written Exposure Therapy
2021
Completed Phase 2
~370
Treatment as Usual
2016
Completed Phase 3
~2710

Find a Location

Who is running the clinical trial?

Potomac Health FoundationsLead Sponsor
4 Previous Clinical Trials
285 Total Patients Enrolled
University of Maryland, Baltimore CountyOTHER
12 Previous Clinical Trials
2,337 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants being recruited for this medical research study?

"Indeed, the details on clinicaltrials.gov highlight that this study is actively seeking volunteers. The trial was initially listed on December 1st, 2022 and its latest update was on March 5th, 2024. This research endeavor aims to enroll a total of 100 participants from one location."

Answered by AI

Are potential participants still being enrolled in this research study at the moment?

"Correct. Information available on clinicaltrials.gov indicates that this particular research study is actively seeking volunteers. The trial was initially listed on December 1, 2022, with the latest update recorded on March 5, 2024. Recruitment aims to enlist a total of 100 participants from one designated site."

Answered by AI
~6 spots leftby Jun 2024